Trans-4-fluoro-3-hydroxypyrrolidine hydrochloride, 95.0%, 1g

n-[(oxolan-2-yl)methyl]morpholine-4-carboxamide, 97%, 250mg

2,2-Bis(4-hydroxyphenyl)hexafluoropropane, 95.0%, 1kg

2,5-Dichloro-3-methylbenzoic acid, 5g

3-Chlorobenzhydrol, 97.0%, 5g

Phenyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrol-1-yl)methanone, 95.0%, 100mg

1-[2-(5-Benzyloxy-2-nitrophenyl)vinyl]pyrrolidine, 1g

2-Ethyl-2-hexenal, 95.0%, 25g

(+/-)-Thalidomide, 98%, 250mg

(2-Cyanopyrimidin-5-yl)boronic acid, 98%, 5g

N-Boc-2-[2-(2-amino-ethoxy)-ethoxy]-ethylamine, 98.0%, 500g

2,3-Dimethyl-1-butene>98.0%(GC)500mL

Methyl 3-(4-methylpiperidin-1-yl)propanoate, 98%, 100mg